The 2021 PDA Pharmaceutical Manufacturing & Quality Virtual Conference will continue on the theme of PDA APAC 2020 conference and will provide an update on the evolving landscape of GMP regulations, in particular Annex 1 requirements. Of particular interest is the inclusion of PUPSIT in Annex 1 including its on-going debate on the interpretation and implementation. We will also touch on key trends in barrier technology in sterile manufacturing as well as quality control microbiology including rapid microbiology, which is of increasing interest in delivering speed for COVID-19 vaccine manufacturing and the growing segment of cell and gene therapy.
Presentations will include topics on:
2021 PDA Cleanroom Qualification: Current Regulatory Expectation
As an extension to this conference, PDA is proud to present a workshop on Cleanroom Qualification: Current Regulatory Expectation happening on Friday, 17 September 2021.
For more information, visit https://bit.ly/PDACleanRoomWorkshop
CEO of Microrite
Vice President at Green Mountain Quality Assurance LLC
Chief Operating Officer at Valsource Inc
Senior Quality & Compliance Specialist at Cell Therapies
Manager, Microbiology at MSD International GmbH
Quality Auditor, Sterility Assurance Expert at Boehringer Ingelheim
Managing Director of Charles River Laboratories (Singapore)
Deputy Director, Office of Manufacturing Quality at US FDA